The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.

[1]  M. Falconi,et al.  A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors , 2018, Annals of surgery.

[2]  E. Nakakura Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix , 2018, Annals of Surgical Oncology.

[3]  B. Zhang,et al.  Revised nodal stage for pancreatic neuroendocrine tumors. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[4]  V. Hervieu,et al.  Lymphadenectomy during Small Bowel Neuroendocrine Tumor Surgery: The Concept of Skip Metastases , 2016, Annals of Surgical Oncology.

[5]  R. Jensen,et al.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors , 2016, Neuroendocrinology.

[6]  M. Büchler,et al.  Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. , 2015, Annals of surgery.

[7]  K. Trinkaus,et al.  Regional Lymphadenectomy Is Indicated in the Surgical Treatment of Pancreatic Neuroendocrine Tumors (PNETs) , 2014, Annals of surgery.

[8]  Toby C. Cornish,et al.  A Single Institution's 26-Year Experience With Nonfunctional Pancreatic Neuroendocrine Tumors: A Validation of Current Staging Systems and a New Prognostic Nomogram , 2014, Annals of surgery.

[9]  A. Scarpa,et al.  Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). , 2013, JAMA surgery.

[10]  E. Nakakura,et al.  Lymph Node Sampling Rates and Predictors of Nodal Metastasis in Pancreatic Neuroendocrine Tumor Resections: The UCSF Experience With 149 Patients , 2012, Pancreas.

[11]  A. Scarpa,et al.  Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections. , 2012, European journal of cancer.

[12]  William Mantovani,et al.  Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients , 2010, Modern Pathology.

[13]  A. Scarpa,et al.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system , 2006, Virchows Archiv : an international journal of pathology.

[14]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.

[15]  B. Pockaj,et al.  Importance of Lymph Node Involvement in Pancreatic Neuroendocrine Tumors: Impact on Survival and Implications for Surgical Resection , 2014, Journal of Gastrointestinal Surgery.

[16]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[17]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.